Leuprolide and aspartate aminotransferase increased Patient Reports February 12, 2012

Leuprolide Side Effects Report #5912430-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 29, 2008. Male patient, 94 years of age, was diagnosed with prostate cancer stage iv, thrombosis prophylaxis, pain  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dyspnoea, oedema peripheral, pneumonia , protein total decreased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, ACETYLSALICYLIC ACID SRT, ETHINYL ESTRADIOL, FENTANYL. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5332500-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on May 17, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: adenocarcinoma, aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiac tamponade, cardiomegaly, hepatic function abnormal, lung neoplasm malignant, lymphadenopathy mediastinal, malaise. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with FLUTAMIDE, PLETAAL, JUVELA N, PROCYLIN, DEPAKENE. Patient recovered.

Leuprolide Side Effects Report #5353027-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 04, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiac tamponade, lung adenocarcinoma, lung neoplasm malignant, lymphadenopathy mediastinal, neck pain, oedema peripheral, pericardial effusion. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with FLUTAMIDE, PLETAAL, JUVELA N, PROCYLIN, DEPAKENE. Patient recovered.

Leuprolide Side Effects Report #5794772-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 16, 2008. Male patient, 75 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, hepatic function abnormal. Leuprolide dosage: unknown. During the same period patient was treated with FLUTAMIDE, BICALUTAMIDE. Patient recovered.


Leuprolide Side Effects Report #5807593-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 75 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, hepatic function abnormal. Leuprolide dosage: unknown. During the same period patient was treated with FLUTAMIDE, BICALUTAMIDE. Patient recovered.

Leuprolide Side Effects Report #5247989-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 19, 2007. Female patient was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiac tamponade, cardiomegaly, hepatic function abnormal, lung neoplasm malignant, lymphadenopathy mediastinal, malaise, neck pain. Leuprolide dosage: 11.25 MG, SUBCUTANEOUS, 1 IN 12 WEEKS. During the same period patient was treated with FLUTAMIDE, PLETAAL, JUVELA N, PROCYLIN, DEPAKENE. Patient recovered.

Leuprolide Side Effects Report #5795678-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 20, 2008. Male patient, 80 years of age, was diagnosed with prostate cancer stage ii, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral infarction, liver disorder. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CHLORMADINONE ACETATE, TAMSULOSIN. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5809699-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 09, 2008. Male patient, 80 years of age, weighting 115.3 lb, was diagnosed with prostate cancer stage ii, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral infarction, liver disorder. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CHLORMADINONE ACETATE, TAMSULOSIN. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5815078-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 09, 2008. Male patient, 80 years of age, weighting 115.3 lb, was diagnosed with prostate cancer stage ii, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral infarction, liver disorder. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CHLORMADINONE ACETATE, TAMSULOSIN. Patient was hospitalized. Patient recovered.


Leuprolide Side Effects Report #4845409-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 17, 2005. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, gamma-glutamyltransferase increased, jaundice , liver disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #4846028-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 28, 2005. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alcoholic liver disease, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, gamma-glutamyltransferase increased, jaundice , liver disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #4875734-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, condition aggravated, dyspepsia, gamma-glutamyltransferase increased, jaundice . Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #4895456-4
Leuprolide side effect was reported by a Health Professional from JAPAN on Jan 23, 2006. Male patient, 73 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, gamma-glutamyltransferase increased, jaundice , liver disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D), SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #4669274-6
Leuprolide side effect was reported by a Consumer or non-health professional from on May 17, 2005. Male patient, 92 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, disseminated intravascular coagulation, rhabdomyolysis. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). Patient was hospitalized. Patient recovered.


Leuprolide Side Effects Report #4686065-0
Leuprolide side effect was reported by a Consumer or non-health professional from on May 31, 2005. Male patient, 92 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, condition aggravated, cyanosis. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). Patient recovered.

Leuprolide Side Effects Report #4745007-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 09, 2005. Male patient, 92 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood culture positive, blood lactate dehydrogenase increased, blood urea increased, condition aggravated, hepatic function abnormal. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient recovered.

Leuprolide Side Effects Report #5277979-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 13, 2007. Male patient, 86 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, brain stem infarction, cerebral circulatory failure, cerebral infarction, eye disorder, eyelid function disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with HARNAL D, BLADDERON, TRYPTANOL. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5245980-X
Leuprolide side effect was reported by a Consumer or non-health professional from BELGIUM on Feb 14, 2007. Male patient, 85 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, atrioventricular block complete, blood lactate dehydrogenase increased, cardiac arrest , cardiogenic shock, cough, dyskinesia. Leuprolide dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM, ERGOCALCIFEROL. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4951393-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 16, 2006. Male patient, 85 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, jaundice . Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CASODEX, URSO, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.


Leuprolide Side Effects Report #4673801-2
Leuprolide side effect was reported by a Consumer or non-health professional from on May 20, 2005. Male patient, 82 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, pneumonia . Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D), SUBCUTANEOUS. During the same period patient was treated with FLUTAMIDE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4820872-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 01, 2005. Male patient, 78 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, antinuclear antibody positive, aspartate aminotransferase increased, b-lymphocyte count increased, blood alkaline phosphatase increased, cardiac disorder, cardiac failure congestive, chromosome banding, condition aggravated. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, NITRODERM, PROSTATE. Patient was hospitalized and became disabled. Patient recovered.

Leuprolide Side Effects Report #5113504-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 15, 2006. Male patient, 76 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, jaundice . Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE, BEZATOL, DORAL, EVAMYL. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5128061-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Oct 06, 2006. Male patient, 76 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, hepatomegaly, jaundice . Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE, BEZATOL, DORAL, EVAMYL. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5151883-1
Leuprolide side effect was reported by a Physician from JAPAN on Nov 07, 2006. Male patient, 76 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dyspepsia, hepatomegaly, jaundice , ocular icterus. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE, CHLORMADINONE ACETATE, BEZATOL, DORAL, EVAMYL. Patient was hospitalized. Patient recovered.


Leuprolide Side Effects Report #4711136-X
Leuprolide side effect was reported by a Physician from JAPAN on July 06, 2005. Male patient, 76 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bedridden, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, central venous pressure decreased, dehydration, dysphagia. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with HALCION, WARFARIN, MAGMITT, POSTERISAN. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #4747072-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2005. Male patient, 76 years of age, was diagnosed with prostate cancer , insomnia, deep vein thrombosis , constipation  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bedridden, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, central venous pressure decreased, dehydration, feeding disorder. Leuprolide dosage: 3.75 MG (3.75 MG,1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with HALCION, WARFARIN, MAGMITT, POSTERISAN. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #4772444-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 02, 2005. Male patient, 76 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bedridden, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, central venous pressure decreased, dehydration. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with HALCION, WARFARIN, MAGMITT, POSTERISAN. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5108514-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Sept 12, 2006. Male patient, 74 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, hepatic cirrhosis, hepatitis c , jaundice , liver disorder, malaise. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28D). During the same period patient was treated with CHLORMADINONE ACETATE. Patient recovered.

Leuprolide Side Effects Report #4772935-1
Leuprolide side effect was reported by a Consumer or non-health professional from GERMANY on Sept 14, 2005. Male patient, 65 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood immunoglobulin a increased, fatigue, gamma-glutamyltransferase increased, hepatic cirrhosis, hepatic steatosis. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 1 M) SUBCUTANEOUS. During the same period patient was treated with DEXAMETHASONE, CORDAREX, DIGIMERCK MINOR, ACETYLSALICYLIC ACID, CODEINE SUL, BERODUAL, SYMBICORT, PANTOZOL. Patient recovered.


Leuprolide Side Effects Report #4644741-X
Leuprolide side effect was reported by a Consumer or non-health professional from on Apr 20, 2005. Male patient was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, jaundice , lymphocyte stimulation test positive. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with LEUPROLIDE ACETATE, WARFARIN, DIGOXIN, FLIVAS, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5863012-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 19, 2008. Female patient, 38 years of age, was diagnosed with breast cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, granulocytopenia, hypochromasia, leukopenia. Leuprolide dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, TAMOXIFEN CITRATE, DOXIFLURIDINE. Patient recovered.